· rebuilt nightly from public records
Signal Sheet
Organogenesis is a listed biotechnology company in Canton, Massachusetts. It raised $130M in Nov 2024 and its filings name 18 officers. Everything below links to the record it came from.
Signed a material agreement
Corporate eventOfficer or director change
New leadershipEquity raise reported to the SEC, Nov 2024.
CapitalPick the companies and territory you sell to and get dated, sourced reasons like these for each one, ranked by who is most likely to buy now. Your list stays yours.
Want this matched to what you sell? Get early access to Pursuit Plans →The most recent events first, refreshed every night. Each links to the record it came from.
| When | What happened | Kind | Source |
|---|---|---|---|
| Aug 6, 2026 | Signed a material agreement | Corporate event | SEC filing |
| Jun 15, 2026 | Officer or director change | New leadership | SEC filing |
| Feb 18, 2026 | Officer or director change | New leadership | SEC filing |
| Dec 22, 2025 | Signed a material agreement | Corporate event | SEC filing |
| Nov 12, 2024 | Raised $130M in equity from 2 investors | Capital | SEC filing |
The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names
| Role | Contact | Source | Why they matter now |
|---|---|---|---|
| Executive Officer | Sr. Gary S. Gillheeney | SEC filing, Nov 2024 | Named officer in the filing; part of the buying group |
| Executive Officer | Patrick Bilbo | SEC filing, Nov 2024 | Named officer in the filing; part of the buying group |
| Executive Officer | David C. Francisco | SEC filing, Nov 2024 | Named officer in the filing; part of the buying group |
| Executive Officer | Lori Freedman | SEC filing, Nov 2024 | Named officer in the filing; part of the buying group |
| Executive Officer | Brian Grow | SEC filing, Nov 2024 | Named officer in the filing; part of the buying group |
| Executive Officer | Antonio Montecalvo | SEC filing, Nov 2024 | Named officer in the filing; part of the buying group |
| Executive Officer | Robert Cavorsi | SEC filing, Nov 2024 | Named officer in the filing; part of the buying group |
| Chief Technology Officer | Alan A. Ades | SEC filing, Nov 2024 | Technology and tooling decisions |
| Chief Technology Officer | Robert Ades | SEC filing, Nov 2024 | Technology and tooling decisions |
| Chief Technology Officer | Michael J. Driscoll | SEC filing, Nov 2024 | Technology and tooling decisions |
| Chief Technology Officer | Prathyusha Duraibabu | SEC filing, Nov 2024 | Technology and tooling decisions |
| Chief Technology Officer | David Erani | SEC filing, Nov 2024 | Technology and tooling decisions |
| Chief Technology Officer | Jon Giacomin | SEC filing, Nov 2024 | Technology and tooling decisions |
| Chief Technology Officer | Michele Korfin | SEC filing, Nov 2024 | Technology and tooling decisions |
| Chief Technology Officer | Arthur S. Leibowitz | SEC filing, Nov 2024 | Technology and tooling decisions |
| Chief Technology Officer | Glenn H. Nussdorf | SEC filing, Nov 2024 | Technology and tooling decisions |
| Chief Technology Officer | Gilberto Quintero | SEC filing, Nov 2024 | Technology and tooling decisions |
| Chief Technology Officer | Garrett Lustig | SEC filing, Nov 2024 | Technology and tooling decisions |
Lakewave finds the right people at Organogenesis, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.
Try it on Organogenesis with a free trial →| Headquarters | Canton, Massachusetts, per the filing address |
| Industry group | Biotechnology |
| Ownership | Listed company |
| Raise history | $130M (Nov 2024) |
Private-sector companies in the same industry group and state, ranked by Rising score.
Yes. Organogenesis reported a $130M equity raise to the SEC on Nov 12, 2024 with 2 investors.
The company's SEC filing, Nov 2024 names Sr. Gary S. Gillheeney (Executive Officer) among its officers.
Canton, Massachusetts, per the address on its SEC filing.
Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.
Start your free trialCompiled from public records and refreshed nightly; last updated Nov 11, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.